By comparing the two figures, it could be seen that the mutation frequency of each gene in the high and low-rating groups was usually different, and the mutation frequency of the thyroid cancer tumor marker BRAF gene was higher in the low-rating group. This evidence concerns the gene BRAF and thyroid cancer.